Consumption of oxygen:A mitochondrial-generated progression signal of advanced cancer. (Oral presentation) 2013/05/06
2.
Oncolytic effects of a fiber knob substituted adenovirus vector to human lung cancer cells. (Poster presentation) 2013/07/05
3.
Antitumor Effect of Alpha1-Adrenoceptor Blockers on Human Urological Cancer Cells. (Poster presentation) 2013/10/03
4.
Crosstalk between ERK and Akt pathways in malignant mesothelioma cells. (Poster presentation) 2013/10/03
5.
Sonic hedgehog and androgens signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer. 2014/09/06
6.
Evaluations of Aldehyde dehydrogenase-1 (ALDH1) immunoreactivity in human lung adenocarcinoma. (Poster presentation,General Lecture) 2014/09/25
7.
Expression of Aldehyde dehydrogenase-1 (ALDH1) and its relationship with clinical parameters in lung adenocarcinoma. (Poster presentation,General Lecture) 2014/09/25
8.
Development of the newly anticancer drug for human bladder cancer. (Poster presentation,General Lecture) 2014/09/26
9.
Salvianolic acid B suppresses growth of malignant pleural mesothelioma. (Oral presentation,General Lecture) 2014/09/26
10.
Newly synthesized anticancer agent HUHS1015(naftopidil analogue) is effective for malignant pleural mesothelioma(MPM). (Poster presentation,General Lecture) 2014/10/22
11.
A drug repositioning approach identifies alpha-1 blockers as drugs of bladder cancer. (Oral presentation,General Lecture) 2015/03/27
12.
Cancer stem cell marker (ALDH1 expression) and its relationship with clinicopathological parameters in lung adenocarcinoma. (Oral presentation,General Lecture) 2015/04/18
13.
Corrrelation of cancer stem cell marker (ALDH1) and molecular tumor markers (EGFR, K-ras, p53) in lung adenocarcinoma (Oral presentation,General Lecture) 2015/04/18
14.
Potent Anti-Mesothelioma Activity by the Novel Naftopidil Analogue HUHS1015,Preclinical Evidence for Treatment. (Oral presentation,General Lecture) 2015/09/08
15.
Naftopidil Is Effective in the Treatment of Malignant Pleural Mesothelioma. (Poster presentation,General Lecture) 2015/09/09
16.
Development of the new anti-cancer drug using drug repositioning methods. (Oral presentation,General Lecture) 2015/10/09
17.
Cancer stem cell markers (ALDH1 and CD133) expression could be associated with a poor prognosis in the patients with lung adnocarcinoma. (Poster presentation,General Lecture) 2016/04/19
18.
Clinical significance of cancer stem cell markers (ALDH1 and CD133) in the patients with lung adenocarcinoma. (Poster presentation,General Lecture) 2016/10/06
Evaluations of aldehyde dehydrogenase-1 (ALDH1) and TP53 expressions in human lung adenocarcinoma. (Poster presentation,General Lecture) 2016/10/06
21.
Antitumor effect of naftopidil against undifferentiated gastric cancer cells. (Poster presentation,General Lecture) 2016/10/07
22.
Expressions of aldehyde dehydrogenase-1 (ALDH1) and TP53 in human lung adenocarcinoma. (Poster presentation,General Lecture) 2017/04/28
23.
Evaluations of aldehyde dehydrogenase-1 (ALDH1) and CD133 expressions in human lung adenocarcinoma. (Poster presentation,General Lecture) 2017/09/28
24.
Naftopidil induces autophagy in undifferentiated gastric cancer cells. (Poster presentation,General Lecture) 2017/09/30
25.
Expressions of aldehyde dehydrogenase-1 (ALDH1) and CD133 in human lung adenocarcinoma. (Poster presentation,General Lecture) 2018/04/07
26.
Lentiviral vector-mediated gene transfer in bladder cancer cells. (Poster presentation,General Lecture) 2018/09/28
27.
Relationships between cancer stem cell markers (ALDH1 & CD133) and disease-free intervals in human lung adenocarcinoma. (Poster presentation,General Lecture) 2018/09/29
28.
Expressions of cancer stem cell markers (ALDH1 & CD133) and those disease-free intervals in human lung adenocarcinoma. (Poster presentation,General Lecture) 2019/04/18
29.
Expressions of cancer stem cell markers (ALDH1 & CD133) and those disease-free intervals (DFI) and survivals in human lung adenocarcinoma. (Poster presentation,General Lecture) 2019/05/16
30.
Expressions of cancer stem cell markers (ALDH1 & CD133) and evaluations of those disease-free intervals (DFI) and survivals in human lung adenocarcinoma. (Poster presentation,General Lecture) 2019/05/23
31.
Combined effect of Lentiviral vector mediated gene transfer and cisplatin. (Poster presentation,General Lecture) 2019/07/22
Evaluations of aldehyde dehydrogenase-1 (ALDH1), CD133 and CD44 expressions in human lung adenocarcinoma. (Poster presentation,General Lecture) 2019/09/27
34.
Lentiviral vector-mediated transfection of tumor suppressor genes in human c ancer cell lines. (Poster presentation,General Lecture) 2019/09/27
35.
Expression of Cancer Stem Cell markers in human lung adenocarcinoma. (Poster presentation,General Lecture) 2019/10/20
36.
Gene transfection against bladder cancer cell line using lentiviral vectors. (Poster presentation,General Lecture) 2019/10/20